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Metabolic Activation
of Benzo(a)pyrene in SENCAR and BALB/c
Mouse Embryo Cell Cultures
by William M. Baird,* Said M. Sebti,*f
and Lori A. Reinsvold*
The metabolism and DNA binding of benzo(a)pyrene [B(a)P] were compared in early passage mouse
embryo cell cultures prepared from SENCAR mice, a strain especially susceptible to two-stage tumori-
genesis, and BALB/c mice, a strain relatively resistant to two-stage tumorigenesis. Cultures from both
strains metabolizedsimilaramountsofB(a)P; however, theproportionofwater-soluble metabolitesformed
was higher inthe BALB/c culturesthan inthe SENCARcultures. Themajormetabolitesformed incultures
from both strains were B(a)P-9,10-diol, B(a)P-7,8-diol and the glucuronic acid conjugate of 3-hydroxy-
B(a)P. The level of binding of B(a)P to DNA was greater in the SENCAR mouse embryo cell cultures
than in the BALB/c cultures after 5, 24, and 48 hr exposure. The major B(a)P-DNA adduct formed in
B(a)P-treated cultures from both strains was the adduct formed by reaction of (+)anti-B(a)P-7,8-diol-
9,10-epoxide [anti-B(a)PDE, the isomer with the epoxide and the benzylic hydroxyl on opposite faces of
the molecule] with the exocyclic amino group ofdeoxyguanosine. Immobilized boronate chromatography
followed by high-performance liquid chromatography demonstrated the presence ofsmall amounts ofsyn-
B(a)PDE (the isomer with the epoxide and benzylic hydroxyl on the same face of the molecule)-DNA
adducts. The proportions ofthese amounts were similar in cultures from both strains. The results suggest
that SENCAR mouse embryo cell cultures may convert less B(a)P to water-soluble metabolites and more
to DNA-binding metabolites than BALB/c mouse embryo cells. If similar differences exist in B(a)P me-
tabolism in the skin of these strains ofmice, it could help to explain the relatively high sensitivity ofthe
SENCAR mice to tumor induction by the two-stage protocol.
Introduction
The susceptibility of rodents to tumor induction by
carcinogenic chemicals depends on both the species and
strain of rodent as well as on the particular type of
carcinogen and the route of administration. The two-
stage initiation-promotion protocol in mouse skin has
been used for over 40 years as an assay for detecting
tumor initiators and promoters (1). The speed and sen-
sitivity ofthis assay weregreatly increasedby Boutwell
and co-workers by breeding strains selected for sus-
ceptibility to initiation by 7,12-dimethylbenz(a)-
anthracene (DMBA) and promotion by croton oil or its
most active component, 12-0-tetradecanoylphorbol-13-
acetate (TPA) (1,2). The SENCAR mice developed by
this procedure are much more susceptible to tumor in-
duction by this protocol than other mice such as BALB/
c mice (3). Slaga et al. (4) have shown that a number of
strains differintheir response tothistreatmentprotocol
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andthat SENCAR mice aremuchmore susceptible than
BALB/cmice toboth complete and two-stage epidermal
carcinogenesis. One component of this difference may
be susceptibility to promotion (5), but there is also evi-
dence for strain-dependent differences in the activation
oftheinitiator. Nebert etal. (6) found thattheinduction
of hydrocarbon metabolizing enzymes as well as tumor
susceptibility varied in DBA/2 and C57B1 mice. The
strain-dependent differences in these enzymes were re-
cently reviewed by Pelkonen and Nebert (7).
Polycyclic aromatic hydrocarbons (PAHs) such as the
environmentalpollutant benzo(a)pyrene [B(a)P] require
metabolic activation toinduce biological effects (8,9). To
trap the metabolites formed from B(a)P, most studies
were carried out either with microsomal fractions from
various tissues or in cells in culture (8). Early passage
rodent embryo cell cultures were found to have high
B(a)P-metabolizing activity (10), and mouse embryo cell
cultures were used to study the metabolism and DNA
binding of B(a)P and other hydrocarbons (11,12). The
first successful method for chromatographic isolation of
B(a)P-DNA adducts was developed using DNA from
B(a)P-treated mouse embryo cell cultures (13). Re-
cently, techniques have been developed to cultureBAIRD ET AL.
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FIGURE 1. Percentage ofB(a)P metabolized by BALB/c and SEN-
CAR mouse embryo cell cultures: (2) BALB/c cell cultures; (M)
SENCAR cellcultures. Cultures wereexposed to0.5p.g[3H]B(a)P
for the times stated, medium samples were removed, extracted
with chloroform:methanol and the percentage of B(a)P remaining
determined by HPLC.
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FIGURE 2. Percentage of water-soluble B(a)P metabolites formed
in BALB/c and SENCAR mouse embryo cell cultures: (J) SEN-
CAR cell cultures; (U) BALB/c cell cultures. Cultures were
treated with [3H]B(a)P and analyzed as described in the legend of
Figure 1. The percentage ofthe total B(a)P metabolites recovered
in the aqueous phase was calculated.
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FIGURE 3. HPLC elution profile of the chloroform-extractable
B(a)P metabolites formed in BALB/c (top) and SENCAR (bottom)
mouse embryo cell cultures. Cultures were exposed to 0.5 ,ug
[3H]B(a)P/mL medium for 24 hr and extracted and chromato-
graphed as described in "Materials and Methods." The elution
positions ofB(a)P metabolite markers are shown by the horizontal
bars.
mouse epidermal keratinocytes and to investigate the
metabolism and DNA binding of B(a)P in those cells
(14-17). Although studies of cells from a number of
strains ofmice have been performed, B(a)P metabolism
and B(a)P-DNA adduct formation in cells from various
strains under identical conditions have not been com-
pared directly to assess the role ofthese factors in the
suceptibility of various strains to tumor induction. The
present study compared the metabolism of B(a)P in
earlypassage embryo cell cultures prepared from SEN-
CAR mice, a sensitive strain of mice in the two-stage
carcinogenesis assay, and BALB/c mice, a relatively
resistant strain ofmice in this assay (3). The activation
of B(a)P to DNA-binding metabolites was also inves-
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FIGURE 4. Percentage of individual B(a)P metabolites formed in
BALB/c (top) and SENCAR (bottom) mouse embryo cell cultures.
Themetabolites were analyzed as described inthelegendofFigure
3. Exposure times were: (2) 5 hr; (U) 24 hr; (0) 48 hr.
tigated in cells from these strains using immobilized-
boronate chromatography followed by high-perfor-
mance liquid chromatography (HPLC) (18), aprocedure
that allows increased resolution ofthe B(a)P-DNA ad-
ducts present.
Materials and Methods
Treatment of Cells
Primary embryo cell cultures were prepared from 15-
day SENCAR orBALB/c mouseembryos(HarlanSpra-
gue-Dawley, Inc., Indianapolis, IN) as described pre-
viously (18). Tertiary monolayer cultures were pre-
pared in 175-cm2 culture flasks with 50 mL minimum
Eagle's medium (Grand Island Biological Co., Grand
Island, NY) containing 10% fetal bovine serum (Reheis
Chemical Co., Phoenix, AZ). [G-3H]B(a)P (Amersham,
Arlington Heights, IL) was diluted with B(a)P (Gold
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FIGURE 5. HPLC elution profile of the chloroform-extractable
B(a)P metabolites present in 3-glucuronidase treated medium
from BALB/c (top) and SENCAR (bottom) mouse embryo cell
cultures. The medium samples were treated with ,-glucuronidase
as described in "Materials and Methods" before extraction and
analysis as described in the legend to Fig. 3. The elution positions
of B(a)P metabolite markers are shown by the horizontal bars.
Label; Aldrich Chemical Co., Milwaukee, WI) to a spe-
cific activity of5 Ci/mmole and added to the cultures at
a final concentration of 0.5 [.g/mL medium.
B(a)P Metabolism
After exposure of cells for 5, 24, and 48 hr, medium
samples were removed, extracted by a two-step chlo-
roform:methanol:water procedure (19), and the amount
ofradioactivity inaliquots ofeachphase wasdetermined
by liquid scintillation counting. To measure the for-
mation of hydrocarbon glucuronides, medium samples
were incubated with 2000 Fishman units ofbovine liver
3-glucuronidase before extraction (19,20). The chloro-
form phases were analyzed by HPLC on a Beckman
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FIGURE 6. Total binding levels of B(a)P to DNA in BALB/c and
SENCAR mouse embryo cell cultures: (Q) BALB/c cell cultures;
(U) SENCAR cell cultures. Cultures were exposed to [3H]B(a)P
forthetimes stated, and the DNA wasisolated and levelofbinding
determined as described in "Materials and Methods".
Model 312 chromatograph equipped with a 4.6 mm x
25 cm Ultrasphere octadecyl silane (5 jum) reverse-
phase column (Beckman Instruments, Inc., St. Louis,
MO). Samples were eluted at 1 mL/min for 40 min with
a linear methanol:water gradient from 11:9 to 17:3 fol-
lowed by 10min at 17:3 (20); 110fractions (0.5mL) were
collected, and radioactivity was determined by liquid
scintillation counting. Reference standards ofB(a)P me-
tabolites were purchased from the Chemical Reposi-
tory, Carcinogenesis Research Program, National Can-
cer Institute.
Analysis of B(a)P-DNA Adducts
After 5, 24, and 48 hr of exposure to B(a)P, the cells
were harvested with trypsin:versene, and the nuclei
were isolated by homogenization of the pellet in a hy-
potonic buffer containingTriton-X and stored at -80°C
(18). The DNA was isolated by treatment with RNase
A (Sigma Chemical Co., St. Louis, MO) and proteinase
K (Sigma) followed by CHCI3:isoamyl alcohol (24:1,
v/v) extraction and ethanol precipitation. After three
repetitions, the DNA was precipitated first with 2-
ethoxyethanol and then with ethanol (18). The DNA
was enzymatically degraded to deoxyribonucleosides
(13). B(a)P-deoxyribonucleoside adducts were isolated
by chromatography on a Quick-Sep Sephadex LH-20
column (Isolab Inc., Akron, OH) (21). One portion was
analyzed by HPLC, and the remainder was analyzed by
boronate chromatography before analysis by HPLC.
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FIGURE 7. HPLC elution profile ofB(a)P-DNA adducts formed in
BALB/c (top) and SENCAR (bottom) mouse embryo cellcultures.
Cultures were exposed to [3H]B(a)P for 24 hr, and the DNA was
isolated, enzymatically degraded to deoxyribonucleosides, and the
B(a)P-deoxyribonucleoside adducts analyzed by HPLC as de-
scribed in "Materials and Methods." The elution position of a
I14C]( +)anti-B(a)PDE-dG adduct that was added to each sample
as a marker is shown by the arrow.
HPLC analyses were carried out on a 25 cm x 4.6
mm Ultrasphere octyl reverse-phase column (Beckman
Instruments, Inc., St. Louis, MO). The column was
eluted with methanol:water (46:54) for 34 min at a flow
rate of 1.0 mL/min, then for 10 min with a linear gra-
dient ofmethanol:water (46:54 to 55:45), followed by 24
min with methanol:water (55:45) (18). Fifteen 1.0-mL
fractions followed by 145 fractions of0.3 mL each were
collected in scintillation vials. Radioactivity was deter-
minedby liquid scintillation countingusingACS (Amer-
sham, Arlington Heights, IL). An aliquot of
[14C]( +)anti-B(a)PDE (the isomer of B(a)P-7,8-diol-
9,10-epoxide with the epoxide and benzylic hydroxyl on
opposite faces ofthe molecule)-deoxyguanosine (dG) ad-
duct, prepared by reaction of [14C]anti-B(a)PDE (Na-
tional CancerInstitute, RadiochemicalRepository)with
calf thymus DNA as described previously (21), was
added to each sample as a marker.
B(a)P-deoxyribonucleoside adduct samples forboron-
ate chromatography were chromatographed on a 1.0 g
column of ([N-(N'-[m-(dihydroxyboryl)phenyl] succi-
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FIGURE 9. Ratio ofanti to syn-B(a)PDE-DNA adducts present in
BALB/c and SENCAR mouse embryo cell cultures: (p) BALB/c
cell cultures; (U) SENCAR cell cultures. The cultures were
treated and B(a)P-DNA adducts analyzed by immobilized boron-
ate chromatography as described in the legend to Figure 8. The
ratioofmaterialeluted inthesorbitolbuffer[anti-B(a)PDE-DNA
adducts] to that eluted in the morpholine buffer [syn-B(a)PDE-
DNA adducts] was calculated.
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FIGURE 8. Immobilized boronate chromatography elution profile
ofB(a)P-DNA adducts from BALB/c (top) and SENCAR (bottom)
mouse embryo cell cultures. Cultures were exposed to [3H]B(a)P
for24hr, andtheB(a)P-deoxyribonucleoside adducts wereisolated
and chromatographed as described in "Materials and Methods."
The arrow indicates the fraction number at which sorbitol was
added to the eluting buffer.
namyl)amino])ethyl cellulose as described previously
(18). The column was eluted with 40 mL of 1 M mor-
pholine (pH 9.0), followed by 40 mL of 1 M morpholine:
10% sorbitol, pH 9.0. Eighty 1.0 mL fractions were
collected, and 0.1 mL aliquots of all fractions were re-
moved and placed in scintillation vials. Radioactivity
was determined by liquid scintillation counting in
Ready-Solv HP(Becknan Instruments, Inc., Fullerton,
CA). Buffer fractions containing radioactivity were
pooled, applied to a Quik-Sep Sephadex LH-20 column,
and the B(a)P-modified deoxyribonucleosides were
eluted with methanol (18).
Results
The metabolism of benzo(a)pyrene was compared in
confluent third passage cultures of SENCAR and
BALB/c mouse embryo cells. The cultures were ex-
posed to [3H]B(a)P and aliquots ofmedia were removed
at 5, 24, and 48 hr for measurement ofmetabolism. The
samples were extracted with chloroform:methanol and
the chloroform phase analyzed by HPLC to determine
the amount of B(a)P metabolized. The percentages of
the B(a)P metabolized are shown in Figure 1. The
BALB/c cells appeared to metabolize slightly more
B(a)Patallthreetimepoints, but noneofthedifferences
were statistically significant. Most ofthe B(a)P was me-
tabolized by cultures from both strains of mice by 24
hr.
The nature of the metabolites formed was investi-
gated by determining the proportion ofthe metabolites
thatremained inthe aqueous-methanolphase afterchlo-
roform extraction. The percentage ofwater-soluble me-
tabolites at each time point is shown in Figure 2. At all
times, the proportion of water-soluble metabolites was
higher in the BALB/c than in the SENCAR cells; the
increased level in the BALB/c samples was statistically
significant in both the 5- and 48-hr samples. The chlo-
roform-extractable metabolites were analyzed by
HPLC, and the metabolite profiles are shown in Figure
3. The major metabolites present in cultures from both
strains were the 9,10-diol and the 7,8-diol, with only
traces ofphenolic metabolites present. The percentages
of the total metabolites that these two diols and two
phenols represent are shown in Figure 4. At the early
times, 5 and 24 hr, the SENCAR cell medium contained
a higher proportion of 9,10-diol than the BALB/c me-
dium. In both cell types, the highest proportion ofthese
primary metabolites was observed at 5 hr, then this
percentage dropped to a very low level by 24 and 48
30000
20000-
10000.
z
0
1000
U.
N
a.
20000-
10000 -
49BAIRD ET AL.
z
0
SORBITOL
5000
2500 A
40 80 120 160
FRACTION NUMBER
FIGURE 10. HPLC elution profile ofthe B(a)P-DNA adducts pres-
ent in the morpholine (top) and sorbitol (bottom) fractions of the
immobilized boronate column eluate of (Fig. 8, top) DNA from
B(a)P-treated BALB/c mouse embryo cell cultures. The samples
were analyzed by HPLC as described in "Materials and Methods."
The elutionpositionofa[`4C]( + )anti-B(a)PDE-dG adductmarker
is shown by the arrow.
hr, presumably due to further metabolism of the pri-
mary metabolites.
To investigate the nature of the water-soluble me-
tabolites formed in the cultures from these two strains
of mice, medium samples were treated with 3-glucu-
ronidase to cleave glucuronide conjugates before chlo-
roform extraction. The HPLC profiles ofthese extracts
(Fig. 5) show the presence of three additional peaks, a
broad peak in the quinone region (Fractions 50-65) and
peaks that chromatographed with markers of 9-hy-
droxy-B(a)P and 3-hydroxy-B(a)P. The 3-hydroxy-
B(a)P peak was much larger than the 9-hydroxy-B(a)P
peak in cells from both strains, and the ratio of 9- to 3-
hydroxy-B(a)P was similar in both.
The binding of B(a)P to DNA was investigated at 5,
24, and 48 hr. At all times, the SENCAR cells contained
a larger amount of B(a)P bound to DNA than the
BALB/c cells (Fig. 6). Binding increased from 5 to 24
hr and continued to increase from 24 to 48 hr in spite
of the fact that almost 80% of the B(a)P had been me-
tabolized by 24 hr.
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FIGURE 11. HPLC elution profile ofthe B(a)P-DNA adducts pres-
ent in the morpholine (top) and sorbitol (bottom) fractions of the
immobilized boronate column eluate (Fig. 8, bottom) ofDNA from
B(a)P-treated SENCAR mouse embryo cell cultures. The samples
were analyzed by HPLC as described in "Materials and Methods."
The elution position of a ['4C](+)anti-B(a)PDE-dG adducct
marker is shown by the arrow.
The B(a)P-DNA adducts present were then analyzed
by HPLC (Fig. 7). Cells from both strains contained
one large adduct peak that coeluted with the adduct
formed by reaction of [14C]anti-B(a)PDE with the ex-
ocyclic amino group of deoxyguanosine (anti-B(a)PDE-
dG) (9). In addition, several smaller adduct peaks were
present, but some were only partially resolved from the
anti-B(A)PDE-dG peak. Toallowtheresolutionofthese
minor adduct peaks, the B(a)P-DNA adducts were sep-
arated into those which contained cis vicinal hydroxyl
groups [such as those formed from anti-B(a)PDE] and
those which did not contain cis vicinal hydroxyl groups
[such as those formed by syn-B(a)PDE, the isomerwith
the epoxide and benzylic hydroxyl on the same face of
the molecule] by immobilized boronate chromatogra-
phy. The column profiles are shown in Figure 8. Al-
though some material eluted in the morpholine buffer
fractions (1-20), the majorportion ofthe adducts eluted
afterthe addition ofsorbitol to the buffer(arrow). Thus,
the majority ofthe DNA adducts in both SENCAR and
BALB/c mouse embryo cells resulted from binding of
the anti-isomer of B(a)PDE to DNA. The ratio of sor-
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bitol buffer-eluted material to morpholine buffer-eluted
material [anti- to syn-B(a)PDE-DNA adducts] is
shown in Figure 9. The ratio increased from less than
2:1 to more than 5:1 in both cell types between 5 and
48 hr, but there was no significant difference between
the ratio present in BALB/c cultures and that present
in SENCAR cell cultures at any time.
The individual B(a)P-DNA adducts present in the
morpholine and sorbitol buffer fractions were analyzed
by HPLC on a reverse-phase C8 column. The profiles
for the BALB/c culture DNA samples are shown in
Figure 10. The sorbitol buffer fractions contained one
major peak that coeluted with the [14C]( +)anti-
B(a)PDE-dG marker and only very small amounts of
three other adducts. The one in fraction 140 eluted in
the same position as an anti-B(a)PDE-deoxyadenosine
marker; the others were unidentified. Although the
morpholine buffer fractions contained a much smaller
proportion ofthetotalmaterial, thismaterialdidcontain
three distinct adduct peaks. The first (fractions 92-98),
which was only partially resolved from the anti-
B(a)PDE-dG peak by HPLC alone (Fig. 7), eluted in
the same position as syn-B(a)PDE-dG and syn-
B(a)PDE-deoxycytidine markers. The largest peak
(fraction 116-121) eluted in the same position as a
marker of syn-B(a)PDE-dG, and the small third peak
eluted in the same relative position as syn-B(a)PDE-
deoxyadenosine. The HPLC profiles from immobilized
boronate column fractions of the B(a)P-DNA adducts
from the SENCAR mouse embryo cell cultures (Fig.
11) contained the same adduct peaks in almost identical
proportions. Previous studies have demonstrated that
the relative proportions of the three peaks within the
morpholine buffer fraction do not change withtime. The
major time-dependent change in the adducts is the in-
crease in the proportion of the (+)anti-B(a)PDE-dG
adduct, which is responsible for the time-dependent in-
crease in the ratio of anti- to syn-B(a)PDE-DNA ad-
ducts (Fig. 9).
Discussion
To determine whether strain-specific differences in
the metabolic activation of B(a)P could help to explain
the difference in tumor susceptibility of BALB/c and
SENCAR mice, B(a)P metabolism and DNA binding
wereinvestigated inembryocellculturespreparedfrom
SENCAR and BALB/c mice. The metabolism studies
demonstrated that both the SENCAR and BALB/c
mouse embryo cell cultures metabolized similar
amounts of B(a)P at all three times studied. The only
difference in B(a)P metabolism between the cells from
the two strains was the higher proportion of water-
soluble metabolites formedinthe BALB/ccultures. This
finding suggests that the BALB/c cells may metabolize
the primary diols and phenols more rapidly and thus
reduce the proportion activated to DNA-binding deriv-
atives. The organic-solvent-extractable B(a)P metabo-
lites in both cells were similar to those found in SEN-
CAR mouse epidermal cell cultures by DiGiovanni et
al. (15). The relative ratio of 9,10-diol to 7,8-diol was
greaterintheembryo cellculturesthanintheSENCAR
epidermal cell cultures (15), butsimilartothat observed
in two epidermal cell lines (15). ,B-Glucuronidase treat-
ment released mainly 3-hydroxy-B(a)P and a small
amount of 9-hydroxy-B(a)P in both SENCAR and
BALB/c mouse embryo cell cultures, a result identical
to that observed in SENCAR epidermal cell cultures
(15). Thus, B(a)P metabolism in the mouse embryo cell
cultures was similar to that reported for epidermal cell
cultures. The pattern of B(a)P metabolism in mouse
embryo cell cultures differed from that observed in Syr-
ian hamster and Wistar rat embryo cell cultures in that
cultures from both ofthe latter species formed a higher
proportion of 9-hydroxy-B(a)P glucuronide conjugates
(22).
The binding of hydrocarbons to DNA in mouse skin
and in mouse embryo cell cultures has been shown to
correlate with the carcinogenic potential of the hydro-
carbon(11,23). InstudiesofB(a)P-DNAbindinginvar-
ious strains ofmice, however, Phillips et al. (24) found
nosignificantdifferencesinthebindingofB(a)PtoDNA
in strains with varying sensitivity to hydrocarbon car-
cinogenesis. The level ofbinding ofB(a)P to DNA was
greateratalltimesinthe SENCAR mouse embryocells
than in the BALB/c mouse embryo cells, a result that
correlates with relative susceptibility of these two
strains to tumor induction. The actual B(a)P-DNA ad-
ducts formed in both were similar, and the (+)anti-
B(a)PDE-deoxyguanosine adductwasthemajoradduct
at all times. There i ere also small amounts oftwo syn-
B(a)PDE-deoxyribonucleoside adducts and syn- and
anti-B(a)PDE-deoxyadenosine adducts, but the rela-
tive proportions of these were almost identical in cells
from both strains. In both the SENCAR and the
BALB/c cell cultures there was a time-dependent in-
crease in the proportion ofthe anti-B(a)PDE-DNA ad-
ducts, a change that resulted from the increase in the
(+)anti-B(a)PDE-dG adduct. The proffle of adducts
forned in the SENCAR mouse embryo cells was very
similar to that reported by Ashurst et al. (25) for SEN-
CAR mouse epidermis in vivo. The high proportion of
the (+)anti-B(a)PDE-dG adduct was also consistent
with the antibody binding studies of Nakayama et al.
(16) in BALB/c epidermis in vivo. Thus the binding of
B(a)P to DNA in mouse embryo cell cultures appears
to be similar to B(a)P-DNA binding in mouse skin.
The B(a)P-DNA adductprofiles inthe mouse embryo
cell cultures differed dramatically from those formed in
Syrian hamster and Wistar and Fisher rat embryo cell
cultures (26). Both the rat and hamster cells contained
a much more complex profile of adducts and exhibited
greatertime-dependent alterations in the adducts pres-
ent. The amount of (+)anti-B(a)PDE-dG adduct pres-
ent in the mouse embryo cell cultures at 24 hrwas much
greater than that found in either the rat or the hamster
embryo cell cultures (26). The (+)enantiomer of anti-
B(a)PDE is the most potent skin tumor initiator ofthe
B(a)PDE enantiomers (27). The results suggest that
both SENCAR and BALB/c mouse embryo cell cultures
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form similar proportions of the major DNA adduct of
(+)anti-B(a)PDE, but the higher level of binding of
B(a)Pto DNAinthe SENCAR mouse embryo cells may
result from formation oflarger amounts ofthis ultimate
carcinogen in SENCAR cells than in BALB/c cells. If
a larger amount of (+)anti-B(a)PDE is also bound to
DNA from SENCAR mouse epidermis, it could help to
explain the increased susceptibility of SENCAR mice
to two-stage carcinogenesis.
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